Cellebrite DI Ltd.
CLBT · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$283,007 | -$81,100 | $120,805 | $71,396 |
| Dep. & Amort. | $10,607 | $10,011 | $9,194 | $7,007 |
| Deferred Tax | -$4,015 | $5,125 | -$2,392 | -$1,638 |
| Stock-Based Comp. | $30,575 | $18,998 | $13,708 | $6,480 |
| Change in WC | $42,047 | $38,519 | -$2,819 | $20,680 |
| Other Non-Cash | $335,964 | $110,505 | -$117,919 | -$67,873 |
| Operating Cash Flow | $132,171 | $102,058 | $20,577 | $36,052 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$8,566 | -$5,231 | -$6,897 | -$5,111 |
| Net Acquisitions | -$2,748 | $0 | $0 | -$20,000 |
| Inv. Purchases | -$334,789 | -$144,317 | -$165,364 | -$21,000 |
| Inv. Sales/Matur. | $198,673 | $129,695 | $83,218 | $94,337 |
| Other Inv. Act. | -$2,043 | -$2,687 | -$2,188 | -$3,000 |
| Investing Cash Flow | -$149,473 | -$22,540 | -$91,231 | $45,226 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $0 | $0 | $0 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | -$100,000 |
| Other Fin. Act. | $20,651 | $21,765 | $13,970 | $31,603 |
| Financing Cash Flow | $20,651 | $21,765 | $13,970 | -$68,397 |
| Forex Effect | -$1,207 | $589 | -$1,644 | -$754 |
| Net Chg. in Cash | $2,142 | $101,872 | -$58,328 | $12,127 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $189,517 | $87,645 | $145,973 | $133,846 |
| End Cash | $191,659 | $189,517 | $87,645 | $145,973 |
| Free Cash Flow | $121,562 | $94,140 | $11,492 | $27,941 |